Updated:
Cantabio Pharmaceuticals Inc.
Cantabio Pharmaceuticals Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001550518, and its reported...
Overview
Cantabio Pharmaceuticals Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001550518, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2018-07-16, it reported net income of USD -2,011,773; total assets of USD 109,426 for the fiscal period ended 2018-03-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.
Company overview
- Legal name
- Cantabio Pharmaceuticals Inc.
- Former names in filing history
- Lion Consulting Group Inc. (2012-05-23 to 2015-08-26)
- Classification
- Company
- Industry (SIC)
- 2834 — Pharmaceutical Preparations
- Headquarters
- Palo Alto, CA, United States
- Incorporated in
- DE
- Fiscal year end
- March 31
- SEC CIK
- 0001550518
Financials
Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.
| Fiscal year | Period end | Net income | Total assets | Cash and equivalents | Operating cash flow |
|---|---|---|---|---|---|
| FY2018USD | -$2.0M | $109,426 | $109,426 | -$623,349 | |
| FY2017USD | -$1.1M | $33,523 | $32,275 | -$973,120 | |
| FY2016USD | -$751,328 | $52,110 | $52,110 | -$564,660 | |
| FY2015USD | -$25,322 | — | — | -$13,371 |
FY2015. Net income, Operating cash flow: shown as originally filed; later filings report different values for the same periods.
Recent SEC filings
| Form | Filed | Period | Filing |
|---|---|---|---|
| 8-K | CURRENT REPORT | ||
| 10-Q | QUARTERLY REPORT | ||
| 8-K | CURRENT REPORT | ||
| 8-K | CURRENT REPORT | ||
| 10-Q | QUARTERLY REPORT | ||
| 8-K | PRIMARY DOCUMENT | ||
| 10-Q | PRIMARY DOCUMENT | ||
| 10-K | PRIMARY DOCUMENT | ||
| 8-K | PRIMARY DOCUMENT | ||
| 8-K | PRIMARY DOCUMENT | ||
| 10-Q | PRIMARY DOCUMENT | ||
| 8-K | PRIMARY DOCUMENT |
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Research Cantabio Pharmaceuticals Inc. in Altss
Track this company’s investors, transactions and relationships in Altss.